For laboratory and research use only. Not for human consumption.
Lab-Grade Purity · 99%+ HPLC & MS Verified, Every Batch US-Based Dispatch · FedEx Express Secure Encrypted Checkout 30+ Research Compounds In Stock For Research Use Only

Researcher Verification

Zama Biosciences sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

I am at least 21 years of age.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Enter your email and receive 15% discount! 🚀

Not a researcher? Exit

Selank (CAS 129954-34-3) is a synthetic seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed by joining the natural immune peptide tuftsin to a short Pro-Gly-Pro tail that makes it more resistant to breakdown. It is studied in neuropeptide and neuroimmune research. This page is a laboratory reference covering its sequence, molecular data, research background, handling, storage and testing. For research use only. Not for human or veterinary use.

Selank 5mg lyophilized research peptide vial, CAS 129954-34-3, Zama Biosciences, research use only
Selank, lyophilized research peptide. Research use only.
Compound Selank
CAS number 129954-34-3
Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
Molecular formula C33H57N11O9
Molecular weight ≈ 751.9 g/mol
Length 7 amino acids, linear
Parent peptide Tuftsin (Thr-Lys-Pro-Arg)
Form supplied Lyophilized powder
Purity specification ≥ 99% by HPLC, identity by mass spectrometry, lot-matched COA

What is Selank?

Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as part of a program building drug candidates from short natural regulatory peptides. Its starting point was tuftsin, a four-residue peptide released from the heavy chain of immunoglobulin G that acts on immune cells such as macrophages. Native tuftsin is broken down within minutes in biological fluids, so the developers added the tripeptide Pro-Gly-Pro to its C-terminus. The resulting heptapeptide is much more stable while keeping the tuftsin sequence intact (Kolomin et al., 2013).

Selank is registered as a medicine in Russia. It is not approved by the US FDA or the European Medicines Agency, and research-grade Selank is a laboratory reagent, not a pharmaceutical product.

Structure and sequence

Selank heptapeptide TKPRPGP structure map: tuftsin fragment plus Pro-Gly-Pro extension
Selank structure map: tuftsin core (blue) and stabilizing Pro-Gly-Pro tail (green).

Research background

Animal and cell results describe biology in specific models and cannot be assumed to translate directly to people.

Reconstitution and handling (laboratory)

See the Reconstitution and Storage guide and Reconstitution and Storage Water.

Storage and stability

How Zama Selank is tested

Frequently asked questions

What is Selank?

A synthetic heptapeptide (TKPRPGP) made by adding a Pro-Gly-Pro tail to the immune peptide tuftsin. It is studied in neuropeptide and neuroimmune research.

What is the CAS number of Selank?

129954-34-3. Its molecular formula is C33H57N11O9 and its molecular weight is about 751.9 g/mol.

How is Selank related to Semax?

Both were developed by the same Russian research group and both carry the same stabilizing Pro-Gly-Pro tail. Selank is built on tuftsin, while Semax is built on a fragment of ACTH.

Is Selank FDA approved?

No. It is registered in Russia but not approved in the US or EU. Research-grade Selank is for laboratory use only.

Researcher access

Selank is available to registered researchers. Sign in or create your researcher account to view Selank →

Related research guides: Semax · DSIP · KPV · Full Research Library

References

  1. Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. Neuroscience & Medicine. 2013;4(4):223–252.
  2. Zozulya AA, Kost NV, Sokolov OY, et al. Bulletin of Experimental Biology and Medicine. 2001;131(4):315–317.
  3. Kasian A, Kolomin T, Andreeva L, et al. Behavioural Neurology. 2017;2017:5091027.

Research Use Only. Selank and all products referenced are sold strictly for in-vitro laboratory research. They are not drugs, supplements or medical devices, and are not for human or veterinary use. This page summarizes published literature and makes no claim about any product. Statements have not been evaluated by the FDA.

Leave a Reply

Your email address will not be published. Required fields are marked *

Let us notify you when it's available We will inform you when the product arrives in stock. Please leave your valid email address below.